ST. LOUIS--(BUSINESS WIRE)--Aug. 8, 2005--Tripos, Inc. (Nasdaq:TRPS), a leading provider of drug discovery informatics products and chemistry research, today announced the release of SYBYL(R) 7.1, the latest version of its leading molecular modeling environment for drug discovery research. Available immediately, SYBYL 7.1 includes several new products, including an innovative new application for ligand-based drug design, and delivers many additional improvements requested by Tripos’ global base of loyal customers.
